<code id='1CEC70E919'></code><style id='1CEC70E919'></style>
    • <acronym id='1CEC70E919'></acronym>
      <center id='1CEC70E919'><center id='1CEC70E919'><tfoot id='1CEC70E919'></tfoot></center><abbr id='1CEC70E919'><dir id='1CEC70E919'><tfoot id='1CEC70E919'></tfoot><noframes id='1CEC70E919'>

    • <optgroup id='1CEC70E919'><strike id='1CEC70E919'><sup id='1CEC70E919'></sup></strike><code id='1CEC70E919'></code></optgroup>
        1. <b id='1CEC70E919'><label id='1CEC70E919'><select id='1CEC70E919'><dt id='1CEC70E919'><span id='1CEC70E919'></span></dt></select></label></b><u id='1CEC70E919'></u>
          <i id='1CEC70E919'><strike id='1CEC70E919'><tt id='1CEC70E919'><pre id='1CEC70E919'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:33
          dose of methadone
          A dose of methadone Kevin D. Liles/AP

          The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

          To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges. 

          advertisement

          The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          The biotech scorecard for the 2nd quarter: 12 industry events to watch
          The biotech scorecard for the 2nd quarter: 12 industry events to watch

          APStockIntroducingSTAT’sBiotechQ2Scorecard,ouremoji-enabledmeansoftracking12make-or-breakeventsexpec

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          EMA weighs against approval for Mirati's lung cancer drug

          AdobeAEuropeanregulatorypanelhasrecommendedagainstapprovalofalungcancerdrugmadebyMiratiTherapeutics,